KMX
54
4
CHK
68
3
PNC
40
3
BK
55
3
AXP
49
3
AMT
30
-2
PEP
48
-6
NVDA
61
-3
ZTS
54
2
HCA
42
3
WU
42
2
HAL
71
6
V
60
2
MNST
62
-3
DNB
37
-4
AIG
51
15
JNPR
51
2
ADSK
52
-2
BBY
41
-3
CVX
44
3
KMX
54
4
CHK
68
3
PNC
40
3
BK
55
3
AXP
49
3
AMT
30
-2
PEP
48
-6
NVDA
61
-3
ZTS
54
2
HCA
42
3
WU
42
2
HAL
71
6
V
60
2
MNST
62
-3
DNB
37
-4
AIG
51
15
JNPR
51
2
ADSK
52
-2
BBY
41
-3
CVX
44
3
Financhill
Back

Zimmer Biomet Holdings 10K Form

Buy
57

ZBH
Zimmer Biomet Holdings

Last Price:
119.44
Seasonality Move:
0.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ZBH News And Ratings

See the #1 stock for the next 7 days that we like better than ZBH

ZBH Financial Statistics

Sales & Book Value

Annual Sales: $6.94B
Cash Flow: $177.3M
Price / Cash Flow: 24.56
Annual Sales: $59.25
Price / Book: 2.02

Profitability

EPS (TTM): 2.41000
Net Income (TTM): $505.6M
Gross Margin: $4.92B
Return on Equity: 4.15%
Return on Assets: 2.38%

Zimmer Biomet Holdings Earnings Forecast

Key Zimmer Biomet Holdings Financial Ratios

  • The Gross Profit Margin over the past 23 years for ZBH is 70.90%.
  • The Selling, General & Administrative Expenses for ZBH have been equal to 39.79% of Gross Profit Margin.
  • The Research & Development expenses have been 5.85% of Revenue.
  • The Interest Expense is 71.22% of Operating Income.
  • The Net Earning history of ZBH is 3.33% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 13 years.

Zimmer Biomet Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Medical Devices
Sector: Healthcare
Current Symbol: ZBH
CUSIP: 98956P
Website: zimmerbiomet.com

Debt

Debt-to-Equity Ratio: 0.47
Current Ratio: 1.96
Quick Ratio: 0.76

Price-to-Earnings

Trailing P/E Ratio: 108.59
Forward P/E Ratio: 14.92

ZBH Technical Analysis vs Fundamental Analysis

Buy
57
Zimmer Biomet Holdings (ZBH) is a Buy

Is Zimmer Biomet Holdings a Buy or a Sell?